Dr Alessia Dalla Pria
Consultant in Infectious Diseases, National Centre for HIV Malignancy, Chelsea and Westminster NHS Trust
About this event
- Date and time Tue 16 Feb 2021 from 2:00pm to 3:00pm
- Location Online
- Organised by Oncology
Designed as an educational programme to offer an expert opinion on the management of patients with COVID-19 and cancer, this unique webinar will present some practical experiences around the multi-disciplinary management of such patients.
Join us to understand the impact of the COVID-19 pandemic in the multi-disciplinary management of patients with cancer, to investigate current evidence surrounding vulnerability of cancer patients to the SARS-Cov-2 infection, and to explore changes in diagnostic and treatment algorithms across malignancies.
This meeting capitalises on the expertise of the OnCovid study investigator, the first multi-centre European study documenting outcomes of patients with both COVID-19 and cancer.
By attending this session, participants will be able to:
- Understand the clinical and pathophysiological basis of COVID-19 infection, with a particular focus on impact on cancer patients
- Appreciate the clinical and biologic factors that portend to disease severity and adverse outcome in patients with cancer and the virus
- Implement risk stratification in routine clinical practice and improve the decision making process in the setting of ongoing SARS-Cov-2 viral transmission in the community
A CPD certificate with 1 CPD credit will be issued to those joining the webinar live as well as those who watch the recording afterwards. Certificates will be issued 7 days after the webinar to those who watch it live and after 30 days for those that watch the recording.
Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted.
This is a pre-recorded webinar which will be made available to delegates on the day of this event.
Join in the conversation online #RSMLive
Follow us on Twitter: @RoySocMed
We would like to thank our sponsor Roche Ltd for their support of this webinar. Please note that the scientific programme and content has not been influenced in any way by the sponsor.
Key speakers
Dr David J. Pinato
Clinical Senior Lecturer and Consultant Medical Oncologist, Chief Investigator of the OnCovid Study, Imperial College London
Professor Mark Bower
Professor of Medical Oncology, National Centre for HIV Malignancy and Chelsea and Westminster NHS Trust
Agenda
View the programme here
Welcome and introduction
Professor Mark Bower (Chair), Consultant Medical Oncologist, National Centre for HIV Malignancy, Chelsea & Westminster NHS Trust and Imperial College London
SARS-Cov-2 infection: a practical guide for the clinician
Dr Alessia Dalla Pria, Consultant in Infectious Diseases, Chelsea & Westminster NHS Trust
SARS-Cov-2 infection in cancer patients: disease mechanisms and clinical outcomes
Dr David James Pinato, Clinical Senior Lecturer and Consultant, Medical Oncologist, Department of Surgery and Cancer, Imperial College London
Panel discussion
Closing remarks
Sponsors
Location
Online
Disclaimer: All views expressed in this webinar are of the speakers themselves and not of the RSM nor the speaker's organisations.
Special rates for difficult times
The RSM wishes to offer healthcare professionals continued learning opportunities during the coronavirus pandemic. The RSM’s weekly COVID-19 Series webinars remain free of charge, while there will be small charges to register for other online education. These fees will enable the RSM to continue its programme of activities and will apply during the course of the pandemic.
Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted.
Webinar recordings will be available for registered delegates up to 30 days after the live webinar, via Zoom. The link will be sent 24 hours after the webinar takes place.
This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.
